OpenSSL SSL_connect: Connection reset by peer in connection to v2.sherpa.ac.uk:443 PuSH - Publication Server of Helmholtz Zentrum München: Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults : Results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.

PuSH - Publication Server of Helmholtz Zentrum München

Wendtner, C.-M. ; Abdel-Rahman, S.* ; Baumert, J.J.* ; Falk, M.H.* ; Krych, M.* ; Santl, M.* ; Hiddemann, W.* ; Issels, R.D.

Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults : Results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.

Eur. J. Cancer 37, 1609-1616 (2001)
DOI
Open Access Green as soon as Postprint is submitted to ZB.
The efficacy of thermochemotherapy in adult patients with primary, recurrent or inadequately resected non-metastatic high-risk soft-tissue sarcomas (STS) was assessed. 54 patients were prospectively treated with four cycles of etoposide, ifosfamide and doxorubicin (EIA) combined with regional hyperthermia (RHT) followed by surgery, another four cycles of EIA without RHT and external beam radiation. The objective response rate was 16% and at a median follow-up time of 57 months, the 4-year estimated rates of local failure-free survival (LFFS), distant metastasis-free survival (DMFS), event-free survival (EFS) and overall survival (OS) were 59% (95% confidence interval (CI) 45–73%), 59% (95% CI 44–73%), 26% (95% CI 14–38%) and 40% (95% CI 27–53%), respectively. OS was in favour of patients responding to neoadjuvant treatment (P=0.073). In comparison to a preceding phase II study including pre- and postsurgical thermochemotherapy (RHT-91), at a 4-year follow-up the RHT-95 study cohort showed an inferior LFFS rate (P=0.027), but this did not affect DMFS (P=0.558) or OS (P=0.126). Hence, postsurgical thermochemotherapy seems critical for local tumour control without affecting survival.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Soft-tissue sarcoma High risk Thermochemotherapy Regional hyperthermia (RHT) Local failure-free survival Overall survival
ISSN (print) / ISBN 0959-8049
e-ISSN 1879-0852
Journal European Journal of Cancer
Quellenangaben Volume: 37, Issue: 13, Pages: 1609-1616 Article Number: , Supplement: ,
Publisher Elsevier
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) CCG Tumor Therapy with Hyperthermia (IMI-KTH)